The novel therapy of the medication represents a significant breakthrough in the management of type 2 diabetes. Unlike existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide029082.blogozz.com/40778276/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment